The NECT Story
About Sleeping Sickness
NECT: Contributions to Its Success
ANECT: Other Studies
HAT Regional Network
NECT: challenges in The Field
Patient’s Story
Sailing Away
Brief News
DND<em>i</em>’s HAT-Related News

HAT Projects Supported by Public
and Private Funds
By Jennifer Katz, Fundraising Manager
Thanks to continuous support from our public and private donors, from 2003 to 2008 DNDi has disbursed EUR 16.5 million for its portfolio of human African trypanosomiasis (HAT) projects. Over the past five years, a pool of seven donors has contributed to fund the HAT portfolio. Forty-seven percent of the funding came from private donors: Médecins Sans Frontières (MSF), the Bill & Melinda Gates Foundation and private foundations based in Lichtenstein, the United States and Switzerland. The rest of the funding, fifty- three percent came from public donors: the Department for International Development in the United Kingdom (DFID), The Ministry of Foreign and European Affairs in France (MAEE), the European Union, IncoDev, Framework Programme 6, and the Spanish Agency for International Cooperation (AECI). DNDi is grateful to these donors for their past and ongoing support of these projects.

Specifically for the NECT project, four donors provided EUR 2 million in support of clinical research phase. DNDi thanks DFID, MAEE, MSF, and a private foundation in Lichtenstein.
Published by Drugs for Neglected Diseases Initiative - 15 Chemin Louis-Dunant 1202 Geneva Switzerland - Photo credits: DNDi unless otherwise stated - Editor: Sadia Kaenzig - Tel: +41 22 906 9230 - Fax: +41 22 906 9231 -